Viewing Study NCT01711866


Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2026-03-08 @ 1:47 AM
Study NCT ID: NCT01711866
Status: COMPLETED
Last Update Posted: 2014-04-07
First Post: 2012-10-18
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease
Sponsor: UCB BIOSCIENCES GmbH
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Idiopathic Parkinson's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rotigotine View
None Neupro View
None Switch View
None Dopamine agonists View